Symmune Therapeutics, LLC

Biotechnology company · Durham, North Carolina, United States

Symmune Therapeutics, LLC is a biotechnology company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2015. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2018.

Profile compiled from public records. Is this your company? Request a correction or update

Symmune Therapeutics at a glance

Typebiotechnology company

HeadquartersDurham, North Carolina, United States

Earliest incorporation on record2015

SEC CIK1749423

What does Symmune Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $125,000 sold (2018).

Frequently asked questions about Symmune Therapeutics

Where is Symmune Therapeutics headquartered?

Symmune Therapeutics, LLC is headquartered in Durham, North Carolina, United States.

What does Symmune Therapeutics do?

Symmune Therapeutics, LLC is a biotechnology company.

When was Symmune Therapeutics founded?

The earliest incorporation on record for Symmune Therapeutics, LLC is in 2015, according to public company registers.

Similar companies

Humacyte, Inc.Durham, North Carolina, United States
Precision Biosciences IncDurham, North Carolina, United States
Xilis, Inc.Durham, North Carolina, United States
inSoma Bio, Inc.Durham, North Carolina, United States
Atsena Therapeutics, Inc.Durham, North Carolina, United States
Scion Neurostim, Inc.Durham, North Carolina, United States
Sapere Bio, Inc.Durham, North Carolina, United States
BioAesthetics CorpDurham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences